Clinical Trial Update: Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

This clinical trial update indicates the phase I study of activated autologous T cells targeting glioma cancer stem cell antigens in patients with recurrent gli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens

Snippet

Sponsor: Jeremy Rudnick, M.D | Conditions: Recurrent Glioblastoma | Phase 1 | Status: WITHDRAWN